ACT-1014-6470
ACT-1014-6470 is an orally active, potent, reversible, and selective C5aR1 antagonist. ACT-1014-6470 demonstrates potent inhibition of C5aR1 activation. ACT-1014-6470 can be used in the research of inflammatory diseases[1][2].
Product Specifications
CAS Number
2363082-87-3
UNSPSC
12352005
Target
Complement System
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C1N(CC2=CC=CC=C2C(F)(F)F)C3=NN(CC(F)(F)C)C=C3CN1C4CCN(C5=C(C)C=CC=C5F)CC4
Molecular Formula
C28H29F6N5O
Molecular Weight
565.55
References & Citations
[1]Sylvie FROIDEVAUX, et al. 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases. WO2019137927A1. WIPO (PCT) . 2019-01-09. |[2]Ort M, et al. First-in-human study with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients. Basic Clin Pharmacol Toxicol. 2022 Aug;131 (2) :114-128.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
301325 250 Pack (250 Panel (s) x 1 Roll)
W/W053/NT/PE-TRI100-250 Marine & IMO Signs & Labels (Adhesive)
Sign In for Pricing
View Details 
AAP66275-100UG 100 µg
SH2D4A Peptide - N-terminal region (AAP66275)
Sign In for Pricing
View Details 
GTR15137008 1 Vial
Lentiviral mouse Gorasp2 shRNA (UAS) - Lentiviral mouse Gorasp2 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details